Switching Therapies in AD
Andrew Blauvelt, MD, discusses switching therapies for atopic dermatitis (AD) treatment.
Read More
AD Treatment: Upadacitinib
Andrew Blauvelt, MD, discusses upadacitinib for the treatment of atopic dermatitis (AD).
JAK Inhibitor Safety
A dermatology expert discusses taking a nuanced approach to interpreting the boxed warnings for JAK inhibitor for atopic dermatitis (AD) treatment.
Treatment Selection in AD
An expert discusses treatment selection for atopic dermatitis (AD) based on short and long-term data.
Pathophysiology of AD Treatments
Andrew Blauvelt, MD, provides an overview of the significance of JAK/Stat pathway inhibition in targeting the pathophysiology of atopic dermatology (AD).
Topical and Systemic Treatments for AD
Andrew Blauvelt, MD, provides an overview of different treatment options that are available for patients with moderate to severe atopic dermatitis (AD).